|
| Home : KARYOPHARM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI |
|
Jan 30
2021 |
KARYOPHARM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Karyopharm Therapeutics Inc. - KPTI |
|
NEW ORLEANS, Jan. 29, 2021 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Karyopharm Therapeutics Inc. (NasdaqGS: KPTI). On February 22,... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/karyopharm-investigation-initiated-by-former-louisiana-attorney-general--kahn-swick--foti-llc-investigates-the-officers-and-directors-of-karyopharm-therapeutics-inc---kpti-301218425.html |
| |
|
Related News
|
» BREAKING NOTICE: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline - AZN
» XOM INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Exxon Mobile Corporation
|
|
|
